Specify Company / Ticker to Get the Summary
Suven Pharmaceuticals Limited
SUVENPHARSuven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was founded in 1989 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Berhyanda Limited. Address: Galaxy Towers, Hyderabad, India, 500081
Analytics
WallStreet Target Price
123 690.47 INRP/E ratio
114.53Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SUVENPHAR
Dividend Analytics SUVENPHAR
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
1 year5Y Average Payout Ratio
18.00 %Dividend History SUVENPHAR
Stock Valuation SUVENPHAR
Financials SUVENPHAR
Results | 2019 | Dynamics |